
MOTS-C 10mg Spray is a research-grade synthetic mitochondrial-derived peptide (MDP) formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Derived from the mitochondrial 12S rRNA gene, MOTS-c (sequence: Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Leu-Pro-Arg-Lys-Pro-Leu) is studied for its capacity to activate AMP-activated protein kinase (AMPK), inhibit the folate cycle, and regulate nuclear gene transcription. Formulated as a stabilized solution, each bottle contains 10mg total active peptide, analytically verified by HPLC to support reproducible scientific investigations.
HPLC certified
Independent analysis
Highest standard
Full traceability
MOTS-C 10mg Spray is a synthetic 16-amino-acid mitochondrial-derived peptide solution designed to evaluate non-invasive mucosal transport kinetics and cellular energy homeostasis signaling. Encoding a direct retrograde signaling molecule from the mitochondrial genome, MOTS-c acts on cellular target pathways to stimulate AMPK phosphorylation by regulating intracellular AICAR levels and folate cycle intermediates. Unlike standard lyophilized powders that require reconstitution, this spray format provides a concentration-verified, pre-dissolved liquid format suitable for direct laboratory dispensing.
Researchers continue to investigate MOTS-c across major areas of endocrinology, including cellular glucose uptake, lipid clearance pathways, mitochondrial biogenesis, and physical endurance kinetics in skeletal muscle. The intranasal spray formulation is of high scientific interest because it allows researchers to study epithelial membrane transport kinetics of mitochondrial peptides and direct olfactory-to-brain CNS peptide uptake pathways without invasive parenteral administration. Formulated with high-purity research-grade materials, MOTS-C 10mg Spray is a specialized molecular tool for laboratories examining cellular metabolism and peptide delivery under controlled conditions.
MOTS-C 10mg Spray is a research-grade synthetic peptide solution developed for laboratory investigations involving cellular energy pathways, mitochondrial biology, and non-invasive delivery methods. Chemically classified as a mitochondrial-derived peptide (MDP) encoded by the mitochondrial 12S rRNA locus, it comprises 16 amino acid residues with the sequence Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Leu-Pro-Arg-Lys-Pro-Leu. As an investigational compound, MOTS-c is studied for its ability to regulate metabolic homeostasis, cross cellular membranes, and interact with the nuclear genome under stress conditions.
From a molecular research perspective, MOTS-C Spray provides a valuable model for investigating the transport kinetics of mitochondrial-derived peptides across epithelial cell layers. Standard peptide studies frequently depend on parenteral routes; however, liquid spray preparations enable researchers to evaluate how medium-sized hydrophobic peptides cross mucosal membranes, interact with tight junctions, and engage localized cellular receptors. This spray format is particularly suited for research involving nasal mucosal cell lines.
Current laboratory investigations examine MOTS-c's role as a metabolic regulator. Upon cellular uptake, the peptide inhibits the folate pathway (specifically targeting folate cycle enzymes such as MTHFD2), resulting in the accumulation of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR). AICAR accumulation activates AMP-activated protein kinase (AMPK), the master regulator of energy balance. This cascade promotes GLUT4 transporter translocation to cell membranes, enhancing insulin sensitivity, cellular glucose uptake, and glycolysis under controlled conditions.
Beyond glucose metabolism, researchers use MOTS-c to explore nuclear-mitochondrial retrograde signaling. Under metabolic stress, MOTS-c translocates from the cytoplasm to the nucleus, where it binds to specific promoter regions alongside transcription factors like TFAM (mitochondrial transcription factor A) and NRF1 (nuclear respiratory factor 1). This nuclear translocation activates the expression of nuclear-encoded genes involved in stress adaptation and mitochondrial biogenesis, which researchers study to analyze cellular survival mechanisms.
In neurobiology and central nervous system (CNS) research, the intranasal spray format provides an optimized experimental model for studying direct blood-brain barrier (BBB) bypass. Researchers evaluate whether mucosal delivery via olfactory or trigeminal nerve pathways facilitates direct transport of MDPs to hypothalamic-pituitary regions. This allows the study of central metabolic regulation, neuroprotective signaling, and mitochondrial maintenance in neurodegenerative models without systemic variables.
Each bottle of MOTS-C 10mg Spray is manufactured using solid-phase peptide synthesis (SPPS), followed by purification and solution formulation steps. The resulting active peptide is dissolved in a stabilized, buffered aqueous solution calibrated to ensure exact concentration per metered spray activation. Quality control protocols include reverse-phase high-performance liquid chromatography (HPLC) for purity verification and liquid chromatography-mass spectrometry (LC-MS) for molecular identity confirmation.
To preserve the stability of the peptide in solution, MOTS-C Spray should be stored under refrigeration (2°C to 8°C) and protected from light. Because hydrophobic mitochondrial peptides can undergo aggregation or degradation in aqueous environments over time, maintaining refrigerated storage and minimizing atmospheric exposure is critical to preserving peptide integrity. Proper handling supports consistent concentration and analytical reproducibility across laboratory protocols.
Scientific interest in MOTS-c continues to expand as researchers seek to characterize its stability, nuclear translocation, and transport kinetics. Nevertheless, many aspects of its cellular signaling and epithelial transport remain active areas of scientific inquiry. Ongoing studies continue to refine the understanding of mitochondrial-derived peptides in biological systems. For this reason, MOTS-C 10mg Spray should be regarded as an investigational compound whose primary value lies in advancing scientific knowledge of mitochondrial receptor biology.
MOTS-C 10mg Spray is supplied exclusively for laboratory research and analytical applications. It is intended for Research Use Only (RUO) and is not approved for human consumption, therapeutic use, veterinary use, or diagnostic purposes.
Be the first to share your experience with this product and help other researchers!

Retatrutide reconstitution reference with 10mg, 20mg, 30mg and 60mg mg-to-mL math, BAC water volume options, U-100 unit conversion and COA checks.

KPV nasal spray research: the 342 Da α-MSH tripeptide, why molecular weight favors nasal absorption, and why no published intranasal KPV study exists.

What Ozempic face is, why rapid GLP-1 weight loss thins the facial fat compartments, and what published GHK-Cu collagen research does and does not show.
(faqs)